adaptive clinical trials

Latest Headlines

Latest Headlines

Pfizer and Roche join Icon's adaptive-trial alliance

Pfizer and Roche are the latest pharma heavyweights to join Icon's consortium of drugmakers working to flesh out new technology for adaptive clinical trials, allowing study sponsors to react to results in real time and maximize efficacy.

BioClinica dives into adaptive trials with latest buy

Just three months after wrapping its latest merger, BioClinica has made another acquisition, snapping up Blueprint Clinical to expand its capabilities in the growing field of risk-based management.

Parexel zeroes in on adaptive trials with its latest eClinical move

As the industry embraces risk-based clinical trial monitoring, Parexel International is expanding its banner eClinical offering to help sponsors make data-driven decisions in the middle of a study.

Icon is buying Aptiv with a focus on adaptive trials

CRO giant Icon has agreed to trade $143.5 million for Aptiv Solutions, looking to complement its own technology in complex trial design and expand its presence in Japan.

Icon rolls out data visualization tech for adaptive trials

Icon, like most of the world's largest CROs, is investing in high-tech adaptive trial monitoring, and the company's latest offering allows investigators to comb through huge dumps of lab data in real time, tracking trial trends as they happen.

J&J exec prescribes adaptive approach to Alzheimer's drug development

Drugmakers have misfired way more than hit their targets in developing new drugs for complex diseases such as Alzheimer's. Dr. Michael Krams, vice president and head of the neurology franchise at Johnson & Johnson ($JNJ), suggests that part of the problem lies in the way pharma companies have designed clinical trials, according to an article from Bio-IT World.

PPD gets high-tech for adaptive trials

As clinical trials get more and more complex, Pharmaceutical Product Development has reached out to technology consultancies Tessella and Berry Consultants to use FACTS, adaptive trial software that lets study designers simulate trials in their early planning stages.

PPD secures adaptive trials software as clinical studies evolve

As drug developers seek efficient ways to study new treatments for complex disease, Pharmaceutical Product Development has tapped adaptive clinical trials software from technology consultancies Tessella and Berry Consultants.

Aptiv nails down software deal to fuel adaptive trials services

Aptiv Solutions has grabbed a key piece to the tech puzzle it has been assembling to provide drug and device developers with adaptive clinical trials. The Reston, VA-based CRO, which launched last...

Aptiv marries IT and CRO services to tackle adaptive trials market

Aptiv Solutions has struck another deal to build its technology offerings in support of complex clinical studies with adaptive designs--also known as adaptive clinical trials. The venture-backed...